Similar articles

• Menopause and the risk of coronary heart disease in women.

  Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Colditz GA, et al. N Engl J Med. 1987 Apr 30;316(18):1105-10. doi: 10.1056/NEJM198704303161801. N Engl J Med. 1987. PMID: 3574358
• [Modern trends in substitutive estrogen therapy in the postmenopausal period. B. Results of the use of an estro-progestogenic association].

  Bubani V, Sansa G. Bubani V, et al. Ann Ostet Ginecol Med Perinat. 1968 Jul;90(7):453-96. Ann Ostet Ginecol Med Perinat. 1968. PMID: 5712636 Italian. No abstract available.
• [Effects of estrogen treatment on coronary insufficiency in women after menopause].

  Potocki J. Potocki J. Pol Tyg Lek. 1971 Nov 22;26(47):1812-5. Pol Tyg Lek. 1971. PMID: 5132739 Polish. No abstract available.
• Oestrogens and postprandial lipid metabolism.

  Westerveld HT, Meyer E, de Bruin TW, Erkelens DW. Westerveld HT, et al. Biochem Soc Trans. 1997 Feb;25(1):45-9. doi: 10.1042/bst0250045. Biochem Soc Trans. 1997. PMID: 9056841 Review. No abstract available.
• [Usefulness of estrogen treatment in prevention of ischemic heart disease in menopausal women].

  Roig Minguell E. Roig Minguell E. Rev Esp Cardiol. 1994;47 Suppl 3:22-6. Rev Esp Cardiol. 1994. PMID: 7816976 Review. Spanish. No abstract available.